Ebola virus vaccine (Novavax)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEbola virus vaccine (Novavax)

Drug Alias NameRecombinant Ebola GP vaccineEBOV-GP VaccineRecombinant Ebola glycoprotein vaccineEbola virus recombinant glycoprotein nanoparticle vaccineEBOV-GP

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovavax

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovavax

Active IndicationsN/A

Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A